NCT01594268View on ClinicalTrials.gov

A Prospective, Open Label Study of CERtican in KIdney Transplantation

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Kidney Transplant
Interventions
DRUG

Everolimus

A prospective, open-label study to assess safety of Certican in kidney transplant patients

Trial Locations (4)

120-752

Novartis Investigative Site, Seoul

135-720

Novartis Investigative Site, Seoul

738-736

Novartis Investigative Site, Seoul

442-721

Novartis Investigative Site, Suwon

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY